Vaxcyte’s (PCVX) “Buy” Rating Reiterated at Guggenheim
Guggenheim reaffirmed their buy rating on shares of Vaxcyte (NASDAQ:PCVX – Free Report) in a research note released on Wednesday,Benzinga reports. Guggenheim currently has a $160.00 target price on the stock. Several other equities analysts have also recently issued reports on PCVX. The Goldman Sachs Group initiated coverage on Vaxcyte in a research report on […]
Guggenheim reaffirmed their buy rating on shares of Vaxcyte (NASDAQ:PCVX – Free Report) in a research note released on Wednesday,Benzinga reports. Guggenheim currently has a $160.00 target price on the stock. Several other equities analysts have also recently issued reports on PCVX. The Goldman Sachs Group initiated coverage on Vaxcyte in a research report on […]
